[Therapeutic effect of natulan in generalized forms of lymphogranulomatosis].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D002214:Capsules; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007962:Leukocytes / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D011344:Procarbazine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012075:Remission, Spontaneous; D013997:Time Factors
D002214:Capsules; D011344:Procarbazine
Lechebnyĭ éffekt natulana pri generalizovannykh formakh limfogranulematoza